Beam drops 9% on phase 1/2 data for genetic lung disease candidate
Beam decreased by 9% to 1/2 phase data for a candidate for genetic lung disease
Report
Similar Posts
A new lawsuit against Meta shows the pitfalls of women in tech and Zuckerberg’s demand for ‘masculine energy’
The former Meta employee judges the company, silenced women’s toxic culture continuously. Read more: Report…
Why a housing market ‘thaw’ never came in 2024
Wall Street analysts had hoped the housing market would show signs of life in 2024. Instead,…
Stocks sink as tariff back-and-forth roils trading: markets wrap
S & P 500 has lost 2%, and NASDAQ 100 is 3%, on the verge of…
Trump nominates Miami-Dade official as ambassador to Panama By Reuters
By Jasper Ward (Reuters) – U.S. President-elect Donald Trump on Wednesday nominated Miami-Dade County Commissioner Kevin…
School shooting in Wisconsin has left ‘multiple injuries,’ police say By Reuters
(Reuters) – Several people were injured in a shooting at a Christian school in Madison, Wisconsin,…
Trump pushes Apple to end DEI, calls programs ‘very bad’ for the United States
Vice President JD Vance removes the post directly with President Donald Trump’s approach to Dey and…
English